Catalogo Articoli (Spogli Riviste)


Pharmacy access to syringes among injecting drug users: Follow-up findingsfrom Hartford, Connecticut
Singer, M; Baer, HA; Scott, G; Horowitz, S; Weinstein, B;
Hispan Hlth Council, Hartford, CT 06106 USA Hispan Hlth Council Hartford CT USA 06106 Council, Hartford, CT 06106 USA Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA Univ Arkansas Fayetteville AR USA 72701 ropol, Fayetteville, AR 72701 USA
Titolo Testata:
, volume: 113, anno: 1999, supplemento:, 1
pagine: 81 - 89
Tipo documento:
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Indirizzi per estratti:
Indirizzo: Singer, M Hispan Hlth Council, 175 Main St, Hartford, CT 06106 USA Hispan Hlth Council 175 Main St Hartford CT USA 06106 06106 USA
M. Singer et al., "Pharmacy access to syringes among injecting drug users: Follow-up findingsfrom Hartford, Connecticut", PUBL HEAL, 113, 1999, pp. 81-89


Objective, To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban onpharmacy sales of syringes without a physician's prescription. In 1993, the Centers for Disease Control and Prevention (CDC) evaluated the impact of the new legislation on access to syringes among injecting drug users (IDUs)and found an initial pattern of expanded access. However, it also found that some pharmacies, after negative experiences with IDU customers, revertedto requiring a prescription, This chapter reports findings from a four-year follow-up study of current IDU access to over-the-counter (OTC) pharmacy syringes in Hartford, Connecticut. Methods, Through structured interviews, brief telephone interviews, and mailed surveys, data on nonprescription syringe sale practices were collectedon 27 pharmacies, including 18 of the 21 pharmacies in Hartford and nine from pharmacies in contiguous towns, during June and July 1997. Interview data on pharmacy syringe purchase from two samples of IDUs, a group of out-of-treatment injectors recruited through street ourtreach, and a sample of users of the Hartford Needle Exchange Program, also are reported. Results. The study found that, while market trends as well as negative experiences have further limited pharmacy availability of nonprescription syringes, pharmacies remain an important source of sterile syringes for IDUs. However, the distribution of access is not even; in some areas of the city it is much easier to purchase nonprescription syringes than in others. All of the seven pharmacies located on the north end of Hartford reported that they had a policy of selling OTC syringes, whereas only six (54.5%) of the pharmacies located on the south end have such a policy. Overt racial discrimination was not found to be a barrier to OTC access to syringes. Conclusions. To further decrease acquired immunodeficiency syndrome (AIDS)risk among IDUs, there is a need for public education to counter empirically unsupported stereotypes about IDUs that diminish their access to health care and AIDS prevention resources and services. In states or cities where pharmacy sale of nonprescription syringes is illegal, policy makers should examine the benefits of removing existing barriers to sterile syringe acquisition. In cases in which pharmacy sale of nonprescription syringes is legal, local health departments should implement educational programs to informpharmacy staff and management about the critically important role low-cost(or cost-free), sterile in HIV prevention.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/07/20 alle ore 07:01:17